The announcement of financial results, especially if they are below market expectations, can lead to a decrease in stock price as investors adjust their expectations based on the new information. Given that Xilio Therapeutics' shares are trading lower, it suggests that the Q4 financial results were not favorable or did not meet investor expectations.